Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGCG (Sunphenon EGCG) in Huntington's chorea
2010-023941-31Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2011
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Huntington disease (HD) comparing Sunphenon EGCG with Placebo (2 arms). Primary endpoint: Primary cognitive composite endpoint. Started Mar 2011; status: completed.
02
Drugs
Sunphenon EGCG
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on 2010-023941-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023941-31.